Clinical Trials/Research

If current therapies are not effectively controlling your graft-versus-host disease, consider participating in a clinical trial. Clinical trials are carefully monitored research studies that test new drugs and therapies.

Patients who participate in a clinical trial have early access to new medications, although there is no guarantee that the drugs being studied will be more effective than standard therapies.

Ask your doctor if there is a clinical trial that is appropriate for you. You can also contact NMDP® Jason Carter Clinical Trials Search & Support for free help to identify GVHD trials you may want to consider. 

The Leukemia & Lymphoma Society also offers assistance to search for clinical trials.

ClinicalTrials.gov is a federally funded database that lists information about clinical trials that are recruiting participants, including patients with GVHD.

National Cancer Institute Chronic GVHD Program

An important resource for people living with chronic GVHD is the National Cancer Institute's Chronic GVHD Program.

Patients between the ages of one and 75 can schedule an appointment for a comprehensive evaluation of their GVHD.

Specialists familiar with how chronic GVHD affects every part of a patient's body conduct the four-day physical examination and make recommendations on how best to manage your disease.

The medical evaluation is free of charge and takes place at the National Cancer Institute in Bethesda, Maryland. The program is part of a clinical trial designed to gather a national database of information about chronic GVHD so that better treatments can be developed. For details call 240-858-3681.

#GVHD

If you use social media, learn more about living with graft-versus-host disease and advances in treatment at #GVHD. Connect with others and show your support for GVHD patients.